Multifunctionality and possible medical application of the BPC 157 peptide: literature and patent review

Literature and patent review of the pentadecapeptide BPC 157. The data evaluated come predominantly from preclinical models; the authors stress the lack of clinical evidence.

Key points

• The review summarises results from preclinical models, predominantly animal models and cell cultures.
• The authors explicitly point out that BPC 157 is not approved as a medicine and that robust human studies are lacking.
• Possible risks arising from the mechanisms studied are also discussed.

Assessment

Evidence type: preclinical. The findings summarised here come from laboratory studies and permit no statements about use in humans. We list the paper as a reference for research, not as a product claim. Profile: BPC-157.